You're reading the free version. Trader adds the live tape and alerts.
Start tracking
LXEO Sale Disclosure
Townsend Richard Nolan · SEC Form 4 · Filed Jul 1, 2026
Sale
Calculated transaction value
$116.24K
Townsend Richard Nolan Chief Executive Officer
LXEO
Lexeo Therapeutics
LXEO
Transaction date
Jul 1, 2026
Public filing date
Jul 1, 2026
Filing lag
Filed same day
LXEO daily price context
Close on/before transaction
$4.45
Jul 1, 2026
First close after public filing
$4.69
Jul 2, 2026
30-day return after filing
-11.94%
Through Jul 31, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 25,947 shares @ $4.48
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001995218-26-000013
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$116.24K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Lexeo Therapeutics, Inc. LXEO Current | Sale | Jul 1, 2026 | $116.24K |
| Lexeo Therapeutics, Inc. LXEO | Award | Jun 29, 2026 | $0 |